ABBV vs MMC · P/E 81, rev $16.99B vs P/E 22, rev $24.46B
AbbVie Inc (ABBV) versus Marsh & McLennan Companies Inc (MMC) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Marsh & McLennan Companies Inc (MMC) is a insurance brokers company listed on US.
Latest reported ABBV revenue for 2026-06-30 was $16.99B. Net income was $3.61B. Revenue was up 13.3% from 2026-03-31 to 2026-06-30. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported MMC revenue for 2024-12-31 was $24.46B. Net income was $4.12B. Revenue was up 7.6% from 2023-12-31 to 2024-12-31. MMC currently screens at market cap $89.82B and trailing P/E 21.9.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. MMC currently screens at market cap $89.82B and trailing P/E 21.9.
Not investment advice. Open the ABBV and MMC stock pages for the full models.
Not investment advice.